| BioID | bio1985 |
| Name | ALOSETRON |
| ChEMBL ID | CHEMBL1110 |
| Molecular Formula | C17H18N4O |
| Molecular Weight | 294.36 |
| Molecular Weight (Monoisotopic) | 294.1481 |
| Type | Small molecule |
| Max Phase | Phase 4 |
| Target ID | Tar12 |
| Target Name | Toll-like receptor 9 (TLR9) |
| Synonyms | A03AE01|ALOSETRON|Alosetron|Lotronex |
| Smiles | Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O |
| Inchi | InChI=1S/C17H18N4O/c1-11-13(19-10-18-11)9-21-8-7-15-16(17(21)22)12-5-3-4-6-14(12)20(15)2/h3-6,10H,7-9H2,1-2H3,(H,18,19) |
| Inchi Key | JSWZEAMFRNKZNL-UHFFFAOYSA-N |
| Molecular Species | NEUTRAL |
| Targets | 160.0 |
| Bioactivities | 443.0 |
| Np Likeness Score | -0.77 |
| Records Key | ['3', 'Alosetron', 'alosetron', 'alosetron', '006, alosetron', '1, Alosetron', 'Alosetron', 'Alosetron', 'ALOSETRON', 'Alosetron', 'Alosetron', 'Alosetron', 'ALOSETRON', 'Alosetron', 'Alosetron', 'ALOSETRON', 'ALOSETRON', 'ALOSETRON', 'BDBM50014558', 'Alosetron_HCL', 'EUB0000857a', 'EUB0000857a', 'COVC-1751753378', 'EUB0000857a', 'alosetron', '262272001', '15'] |
| Records Name | ['5-methyl-2-((4-methyl-1H-imidazol-5-yl)methyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one', 'Alosetron', 'alosetron', 'alosetron', '5-methyl-2-((4-methyl-1H-imidazol-5-yl)methyl)-3,4-dihydro-2H-pyrido[4,3-b]indol-1(5H)-one', '5-methyl-2-((4-methyl-1H-imidazol-5-yl)methyl)-3,4-dihydro-2H-pyrido[4,3-b]indol-1(5H)-one', '5-Methyl-2-(5-methyl-1H-imidazol-4-ylmethyl)-2,3,4,5-tetrahydro-pyrido[4,3-b]indol-1-one', 'Alosetron', 'Alosetron', '5-Methyl-2-(5-methyl-1H-imidazol-4-ylmethyl)-2,3,4,5-tetrahydro-pyrido[4,3-b]indol-1-one', 'Alosetron', 'Alosetron', 'ALOSETRON', 'Alosetron', 'Alosetron', 'ALOSETRON', 'ALOSETRON', 'ALOSETRON', 'ALOSETRON::CHEBI:253342::Lotronex::US9045501, Alosetron', 'Alosetron_HCL', 'ALOSETRON', 'ALOSETRON', 'ALOSETRON', 'ALOSETRON', 'alosetron', 'ALOSETRON', 'Alosetron'] |
| Withdrawn Flag | False |
| Orphan | 0 |